• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Parkinsons Library

Gene- and cell-based approaches for neurodegenerative disease.

150 150 NZ Stem Cell Treatment Centre

Adv Exp Med Biol. 2010; 671 : 117-30. Gene- and cell-based approaches for neurodegenerative disease. Urbaniak Hunter K, Yarbrough C, Ciacci J. Department of Radiation Oncology, Univesity of Michigan, Ann Arbor, Michigan, USA. kurbania@med.umich.edu Abstract Neurodegenerative diseases comprise an important group ofchronic diseases that increase in incidence with rising age. In particular, the two most…

read more

Stem cell and gene therapies for neurological disorders and intractable epilepsy.

150 150 NZ Stem Cell Treatment Centre

Neuropharmacology. 2010 May; 58(6) : 855-64. Epub 2010 Feb 8. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Department of Biology and Program in Neuroscience and Behavior, Hall Atwater Laboratory, 52 Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA.…

read more

Stem cell therapy for Parkinson’s disease.

150 150 NZ Stem Cell Treatment Centre

Stem Cells Dev. 2010 Mar; 19(3) : 311-20. Stem cell therapy for Parkinson’s disease: a road map for a successful future. Vidaltamayo R, Bargas J, Covarrubias L, Hernández A, Galarraga E, Gutiérrez-Ospina G, Drucker-Colin R. Depto de Neurociencias and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México. Abstract Cell transplant therapy for Parkinson’s…

read more

Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease.

150 150 NZ Stem Cell Treatment Centre

Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…

read more

Stem cell transplantation in Parkinson’s disease.

150 150 NZ Stem Cell Treatment Centre

Transl Res. 2010 Feb; 155(2) : 62-70. Epub 2009 Aug 6. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. Advanced Neuroscience Institute, BGS-Global Hospital, Bangalore, India. drnkvr@gmail.com Comment…

read more

Treatment strategies for Parkinson’s disease.

150 150 NZ Stem Cell Treatment Centre

Neurosci Bull. 2010 Feb; 26(1) : 66-76. Treatment strategies for Parkinson’s disease. Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P. Department of Integrated Traditional Chinese and Western Medicine, the General Hospital of Chinese People’s Armed Police Forces , Beijing 100039, China. blsphd2005@126.com Abstract Parkinson’s disease…

read more

Clinical application of patient-specific pluripotent stem cells

150 150 NZ Stem Cell Treatment Centre

J Clin Invest. 2010 Jan 4; 120(1) : 51-9. doi: 10.1172/JCI40553. Progress toward the clinical application of patient-specific pluripotent stem cells. Kiskinis E, Eggan K. The Stowers Medical Institute, Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA. ekiskinis@mcb.harvard.edu Abstract Induced pluripotent stem (iPS)…

read more

Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation.

150 150 NZ Stem Cell Treatment Centre

Curr Neurovasc Res. 2010 Feb 1; 7(1) : 49-58. Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation. Yalvaç ME, Ramazanoglu M, Tekguc M, Bayrak OF, Shafigullina AK, Salafutdinov II, Blatt NL, Kiyasov AP, Sahin F, Palotás A, Rizvanov AA. Department of Genetics and BioEngineering, College of Engineering and Architecture, Yeditepe University, Campus,…

read more

Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications-

150 150 NZ Stem Cell Treatment Centre

Adv G erontol. 2009; 22(1) : 150-66. Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications- [Article in Russian] Anisimov SV. Abstract Motor dysfunctions in Parkinson’s disease are believed to be primarily due to the degeneration of dopaminergic neurons located in the substantia nigra pars compacta. Numerous cell replacement therapy approaches have been developed…

read more

Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications-

150 150 NZ Stem Cell Treatment Centre

Stem Cells Dev. 2010 Jul; 19(7) : 1017-23. Cell therapy for Parkinson’s disease: II. Somatic stem cell-based applications- Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Farber Institute for Neurosciences, Department of Neurology, Thomas Jefferson University , Philadelphia, PA 19107, USA. Abstract Cell replacement therapy could be an important treatment strategy…

read more